Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucokinase-activating ureas.

Arlindo L Castelhano1, Hanqing Dong, Matthew C T Fyfe

  • 1OSI Pharmaceuticals, 1 Bioscience Park Drive, Farmingdale, NY 11735, USA.

Bioorganic & Medicinal Chemistry Letters
|February 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding Site.

ACS medicinal chemistry letters·2026
Same author

Real-world use of HIF-PH inhibitors and ESAs in non-dialysis-dependent CKD with anaemia: insights from a Japanese database study.

Current medical research and opinion·2025
Same author

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan.

Advances in therapy·2025
Same author

Correction to "PROTACs Targeting BRM (SMARCA2) Afford Selective <i>In Vivo</i> Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models".

Journal of medicinal chemistry·2025
Same author

Multilayer SiO<sub></sub> derived from Si-Ca alloy <i>via</i> Fe<sub>2</sub>O<sub>3</sub> oxidization for Li-ion batteries.

Dalton transactions (Cambridge, England : 2003)·2025
Same author

X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates.

Antiviral research·2024
Same journal

Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates.

Bioorganic & medicinal chemistry letters·2026
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
See all related articles

New urea compounds activate glucokinase, an enzyme crucial for glucose regulation. These compounds effectively lowered blood glucose levels in mice, offering potential for diabetes therapy.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Endocrinology

Background:

  • Glucokinase plays a critical role in glucose homeostasis.
  • Dysregulation of glucokinase is implicated in diabetes mellitus.
  • Targeting glucokinase presents a therapeutic strategy for diabetes.

Purpose of the Study:

  • To synthesize and evaluate novel urea derivatives as glucokinase activators.
  • To explore the structure-activity relationships (SAR) of these compounds.
  • To assess the in vivo efficacy of glucokinase activators in a preclinical model.

Main Methods:

  • Chemical synthesis of a series of urea compounds.
  • In vitro biochemical assays to determine glucokinase activation.
  • In vivo studies in C57BL/6J mice to measure blood glucose reduction after oral administration.

Related Experiment Videos

Main Results:

  • Several synthesized urea compounds demonstrated potent glucokinase activating properties.
  • Structure-activity relationship analysis identified key structural features for activation.
  • Oral administration of selected urea activators led to significant lowering of blood glucose levels in mice.

Conclusions:

  • Urea derivatives represent a promising class of glucokinase activators.
  • These compounds hold potential as a novel therapeutic approach for managing diabetes.
  • Further development of these activators could lead to new diabetes treatments.